Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 10, Octobre 2012
Page(s) 845 - 851
Section Récepteurs couplés aux protéines G
DOI https://doi.org/10.1051/medsci/20122810012
Publié en ligne 12 octobre 2012
  1. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965 ; 12 : 88–118. [CrossRef] [PubMed]
  2. Changeux JP. Allosteric receptors: from electric organ to cognition. Annu Rev Pharmacol Toxicol 2010 ; 50 : 1–38. [CrossRef] [PubMed]
  3. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006 ; 5 : 993–996. [CrossRef] [PubMed]
  4. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008 ; 7 : 339–357. [CrossRef] [PubMed]
  5. Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2008 ; 153 : S339–S346. [CrossRef] [PubMed]
  6. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002 ; 1 : 727–730. [CrossRef] [PubMed]
  7. Sigel E. Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002 ; 2 : 833–839. [CrossRef] [PubMed]
  8. Conn PJ, Christopoulos A, Lindsley CW. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 2009 ; 8 : 41–54. [CrossRef] [PubMed]
  9. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007 ; 47 : 1–51. [CrossRef] [PubMed]
  10. Kenakin T, Miller LJ. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010 ; 62 : 265–304. [CrossRef] [PubMed]
  11. Hall DA. Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation. Mol Pharmacol 2000 ; 58 : 1412–1423. [PubMed]
  12. Smit MJ, Vischer HF, Bakker RA, et al. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 2007 ; 47 : 53–87. [CrossRef] [PubMed]
  13. Macarron R, Banks MN, Bojanic D, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 2011 ; 10 : 188–195. [CrossRef] [PubMed]
  14. Emkey R, Rankl NB. Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader. Methods Mol Biol 2009 ; 565 : 145–158. [CrossRef] [PubMed]
  15. Pantel J, Williams SY, Mi D, et al. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay. Eur J Pharmacol 2011 ; 660 : 139–147. [CrossRef] [PubMed]
  16. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol 2011 ; 162 : 1239–1249. [CrossRef] [PubMed]
  17. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4 : 67–73. [CrossRef] [PubMed]
  18. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001 ; 2 : 274–286. [CrossRef] [PubMed]
  19. Bockaert J, Perroy J, Becamel C, et al. GPCR interacting proteins (GIP) in the nervous system: roles in physiology and pathologies. Annu Rev Pharmacol Toxicol 2010 ; 50 : 89–109. [CrossRef] [PubMed]
  20. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010 ; 9 : 373–386. [CrossRef] [PubMed]
  21. Milligan G, Smith NJ. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci 2007 ; 28 : 615–620. [CrossRef] [PubMed]
  22. Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov 2011 ; 10 : 507–519. [CrossRef] [PubMed]
  23. Keov P, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 2011 ; 60 : 24–35. [CrossRef] [PubMed]
  24. Wood MR, Hopkins CR, Brogan JT, et al. Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry 2011 ; 50 : 2403–2410. [CrossRef] [PubMed]
  25. Harrington PE, Fotsch C. Calcium sensing receptor activators: calcimimetics. Curr Med Chem 2007 ; 14 : 3027–3034. [CrossRef] [PubMed]
  26. Dorr P, Westby M, Dobbs S, et al. Maraviroc (UK-427, 857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005 ; 49 : 4721–4732. [CrossRef] [PubMed]
  27. Urwyler S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 2011 ; 63 : 59–126. [CrossRef] [PubMed]
  28. Ollmann MM, Wilson BD, Yang YK, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997 ; 278 : 135–138. [CrossRef] [PubMed]
  29. Massot O, Rousselle JC, Fillion MP, et al. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors. Mol Pharmacol 1996 ; 50 : 752–762. [PubMed]
  30. Lazareno S, Dolezal V, Popham A, Birdsall NJ. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol 2004 ; 65 : 257–266. [CrossRef] [PubMed]
  31. Jockers R, Gbahou F, Kamal M, Tadagaki K. Oligomérisation des protéines humaines et virales à 7 domaines transmembranaires : nouvelle stratégie virale pour manipuler la cellule hôte. Med Sci (Paris) 2012 ; 28 : 864–869. [CrossRef] [EDP Sciences] [PubMed]
  32. Galès C. Plasticité des récepteurs couplés aux protéines G et signalisation : un Rubik's cube. Med Sci (Paris) 2012 ; 28 : 883–885. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.